Roche Diagnostics India introduces a point-of-care NT-proBNP test for diabetes patients at risk of heart failure on the cobas h 232 system.
Roche Diagnostics India introduces a point-of-care NT-proBNP test for diabetes patients at risk of heart failure and cardiovascular diseases. The test, available on the cobas h 232 system, enables faster and more efficient diagnosis and management of heart failure in type 2 diabetes patients. The launch aims to revolutionise patient care by bringing testing closer to clinics, particularly in developing countries like India, where diabetes prevalence is high.
9 months ago
5 Articles
Further Reading
You have 9 free stories remaining this month. Subscribe anytime for unlimited access.